Bariatric surgery, such as gastric bypass or gastric banding, could reduce the risk of developing type 2 diabetes by around 80 per cent in obese people, compared with standard care, new research has found.
Monthly Archives: November 2014
CPsychI announces the John Dunne medal winner
Dr John Lally has been selected as winner of the John Dunne Medal 2013 for “an important and invaluable contribution to the literature on Ireland’s psychiatric services”, the College of Psychiatrists of Ireland has announced.
Digital campaign launched for psoriasis patients
The Irish Skin Foundation recently launched its online #SaySomething campaign to mark World Psoriasis Day, which fell last week (October 29).
Biggest consultant shortfalls found in Waterford and the North East
There are a total of 226 consultant vacancies nationally, with the greatest number to be filled at University Hospital Waterford, which has 23 posts vacant.
College President outlines ambitious plans
Newly appointed RCPI President Prof Frank Murray plans to establish a Health Policy Institute during his three-year tenure to research and develop policies that can improve public health.
Spiriva Respimat – New Indication for Treatment of Asthma
Download pdf Spiriva Respimat (tiotropium) is now indicated for add-on maintenance bronchodilator treatment in adults with asthma currently treated with inhaled corticosteroids (≥800mcg daily of budesonide or equivalent) and long-acting ß2 agonists (LABAs) and who experienced one or more severe exacerbations in the previous year.
Jardiance ▼ – Approved for Treatment of Type 2 Diabetes
Download PDF Boehringer Ingelheim Ireland Ltd.
New Treatment Option for Type 2 Diabetes Mellitus – SGLT2 Inhibitors
Download PDF Sodium glucose co-transporter 2 (SGLT2) inhibitors are a novel class of drugs indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control as monotherapy or as combination therapy with other glucose-lowering agents.
Type 2 Diabetes – Individualising Glycaemic Targets and Pharmacotherapy
Download PDF The Global Partnership for Effective Diabetes Management advocates an individualised therapeutic approach and has identified specific type 2 diabetes patient subgroups that require special consideration and proposed practical advice for setting glycaemic targets and tailoring treatment management for these groups.
Transdermal Fentanyl – Reminder about the Potential for Life-Threatening Harm from Accidental Exposure
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) recently completed a review of global reports of accidental exposure to transdermal fentanyl patches.